Cargando…
Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex
Hepatocellular carcinoma (HCC) has a high mortality rate due to the lack of effective treatments and drugs. Arsenic trioxide (ATO), which has been proved to successfully treat acute promyelocytic leukemia (APL), was recently reported to show therapeutic potential in solid tumors including HCC. Howev...
Autores principales: | Wang, Hai-Yang, Zhang, Biao, Zhou, Jun-Nian, Wang, Dong-Xing, Xu, Ying-Chen, Zeng, Quan, Jia, Ya-Li, Xi, Jia-Fei, Nan, Xue, He, Li-Juan, Yue, Wen, Pei, Xue-Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560089/ https://www.ncbi.nlm.nih.gov/pubmed/31186405 http://dx.doi.org/10.1038/s41419-019-1676-0 |
Ejemplares similares
-
Protective effects of oxymatrine against arsenic trioxide-induced liver injury
por: Li, Li, et al.
Publicado: (2016) -
Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma
por: Lu, Wei, et al.
Publicado: (2017) -
Ameliorative effects and mechanism of crocetin in arsenic trioxide-induced cardiotoxicity in rats
por: Zhao, Zhifeng, et al.
Publicado: (2020) -
Immunosuppressive effect of arsenic trioxide on islet xenotransplantation prolongs xenograft survival in mice
por: Zhao, Bin, et al.
Publicado: (2018) -
hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide
por: HE, JIN-HUA, et al.
Publicado: (2013)